Myozyme Approved - Genzyme Corp. - Treatment for Pompe Disease
Myozyme is a recombinant formulation of the human enzyme acid alpha-glucosidase (GAA) indicated for use in patients with Pompe disease (GAA deficiency), a debilitating and often fatal muscle disorder.Posted: April 2006
Related Articles:
- Genzyme Provides Update on U.S. Marketing Application for Myozyme - January 17, 2006
- Genzyme Submits BLA for Myozyme for Treatment of Pompe Disease - July 29, 2005
